Intradialytic Hypertension: A Less-Recognized Cardiovascular Complication of Hemodialysis

American Journal of Kidney Diseases

Volumn 55, Issue 3, 2010, Pages 580-589

  Inrig, Jula K ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

blood pressure; end stage renal disease; hemodialysis; hypertension; Intradialytic hypertension

Indexed keywords

AMLODIPINE; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; ATENOLOL; AVOSENTAN; BENAZEPRIL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CANDESARTAN; CAPTOPRIL; CARVEDILOL; CLONIDINE; DILTIAZEM; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; EPROSARTAN; ERYTHROPOIETIN; FOSINOPRIL; HYDRALAZINE; IRBESARTAN; LABETALOL; LISINOPRIL; LOSARTAN; METOPROLOL; MINOXIDIL; NICARDIPINE; RAMIPRIL; TELMISARTAN; UNINDEXED DRUG; VALSARTAN;

ADRENERGIC SYSTEM; ARTERIAL STIFFNESS; CLINICAL TRIAL; ENDOTHELIAL DYSFUNCTION; ENDOTHELIUM CELL; HEART HEMODYNAMICS; HEMODIALYSIS; HOSPITALIZATION; HUMAN; HYPERTENSION; PATHOGENESIS; POTASSIUM BLOOD LEVEL; PREVALENCE; PROGNOSIS; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; SODIUM BLOOD LEVEL; SURVIVAL RATE;

HEMODYNAMICS; HUMANS; HYPERTENSION; RENAL DIALYSIS;

EID: 77049084961     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.ajkd.2009.08.013     Document Type: Review

References (53)

1. Levin N.W. Intradialytic hypertension: I. Semin Dial 6 (1993) 370-371
2. Fellner S.K. Intradialytic hypertension: II. Semin Dial 6 (1993) 371-373
3. Chen J., Gul A., and Sarnak M.J. Management of intradialytic hypertension: the ongoing challenge. Semin Dial 19 (2006) 141-145
4. Inrig J.K., Oddone E.Z., Hasselblad V., et al. Association of intradialytic blood pressure changes with hospitalization and mortality rates in prevalent ESRD patients. Kidney Int 71 (2007) 454-461
5. Inrig J.K., Patel U.D., Toto R.D., and Szczech L.A. Association of blood pressure increases during hemodialysis with 2-year mortality in incident hemodialysis patients: a secondary analysis of the Dialysis Morbidity and Mortality Wave 2 Study. Am J Kidney Dis 54 (2009) 881-890
6. Chou K.J., Lee P.T., Chen C.L., et al. Physiological changes during hemodialysis in patients with intradialysis hypertension. Kidney Int 69 (2006) 1833-1838
7. Raj D.S., Vincent B., Simpson K., et al. Hemodynamic changes during hemodialysis: role of nitric oxide and endothelin. Kidney Int 61 (2002) 697-704
8. Amerling R.C.G., Dubrow A., Levin N.W., and Osheroff R. Complications During Hemodialysis (1995), Appleton & Lange, Stamford, CT
9. Cirit M., Akcicek F., Terzioglu E., et al. Paradoxical rise in blood pressure during ultrafiltration in dialysis patients. Nephrol Dial Transplant 10 (1995) 1417-1420
10. Mees D. Rise in blood pressure during hemodialysis-ultrafiltration: a "paradoxical" phenomenon?. Int J Artif Organs 19 (1996) 569-570
11. Sarkar S.R., Kaitwatcharachai C., and Levin N.W. Complications During Hemodialysis (2005), McGraw-Hill Professional, New York
12. Reddan D.N., Szczech L.A., Hasselblad V., et al. Intradialytic blood volume monitoring in ambulatory hemodialysis patients: a randomized trial. J Am Soc Nephrol 16 (2005) 2162-2169
13. Inrig J.K., Patel U.D., Gillespie B.S., et al. Relationship between interdialytic weight gain and blood pressure among prevalent hemodialysis patients. Am J Kidney Dis 50 (2007) 108-118 118.e1-4
14. National Kidney Foundation. K/DOQI Clinical Practice Guidelines on Hypertension and Antihypertensive Agents in Chronic Kidney Disease. Am J Kidney Dis 43 suppl 1 (2005) S1-S290
15. Stidley C.A., Hunt W.C., Tentori F., et al. Changing relationship of blood pressure with mortality over time among hemodialysis patients. J Am Soc Nephrol 17 (2006) 513-520
16. Li Z., Lacson Jr. E., Lowrie E.G., et al. The epidemiology of systolic blood pressure and death risk in hemodialysis patients. Am J Kidney Dis 48 (2006) 606-615
17. Zager P.G., Nikolic J., Brown R.H., et al. U Curve association of blood pressure and mortality in hemodialysis patients. Kidney Int 54 (1998) 561-569
18. Rahman M., Griffin V., Kumar A., Manzoor F., Wright Jr. J.T., and Smith M.C. A comparison of standardized versus "usual" blood pressure measurements in hemodialysis patients. Am J Kidney Dis 39 (2002) 1226-1230
19. Agarwal R., Peixoto A.J., Santos S.F.F., and Zoccali C. Pre- and postdialysis blood pressures are imprecise estimates of interdialytic ambulatory blood pressure. Clin J Am Soc Nephrol 1 (2006) 389-398
20. Mendes R.B., Santos S.F., Dorigo D., et al. The use of peridialysis blood pressure and intradialytic blood pressure changes in the prediction of interdialytic blood pressure in haemodialysis patients. Blood Press Monit 8 (2003) 243-248
21. Gunal A.I., Karaca I., Celiker H., Ilkay E., and Duman S. Paradoxical rise in blood pressure during ultrafiltration is caused by increased cardiac output. J Nephrol 15 (2002) 42-47
22. Boon D., van Montfrans G.A., Koopman M.G., Krediet R.T., and Bos W.J. Blood pressure response to uncomplicated hemodialysis: the importance of changes in stroke volume. Nephron Clin Pract 96 (2004) c82-c87
23. Chaignon M., Chen W.T., Tarazi R.C., Nakamoto S., and Bravo E.L. Blood pressure response to hemodialysis. Hypertension 3 (1981) 333-339
24. Converse Jr. R.L., Jacobsen T.N., Toto R.D., et al. Sympathetic overactivity in patients with chronic renal failure. N Engl J Med 327 (1992) 1912-1918
25. Park J., Campese V.M., Nobakht N., and Middlekauff H.R. Differential distribution of muscle and skin sympathetic nerve activity in patients with end-stage renal disease. J Appl Physiol 105 (2008) 1873-1876
26. Bazzato G., Coli U., Landini S., et al. Prevention of intra- and postdialytic hypertensive crises by captopril. Contrib Nephrol 41 (1984) 292-298
27. Erkan E., Devarajan P., and Kaskel F. Role of nitric oxide, endothelin-1, and inflammatory cytokines in blood pressure regulation in hemodialysis patients. Am J Kidney Dis 40 (2002) 76-81
28. El-Shafey E.M., El-Nagar G.F., Selim M.F., El-Sorogy H.A., and Sabry A.A. Is there a role for endothelin-1 in the hemodynamic changes during hemodialysis?. Clin Exp Nephrol 12 (2008) 370-375
29. National Kidney Foundation. K/DOQI Clinical Practice Guidelines for Cardiovascular Disease in Dialysis Patients. Am J Kidney Dis 45 suppl 4 (2005) S49-S59 S69-75
30. Abraham P.A., and Macres M.G. Blood pressure in hemodialysis patients during amelioration of anemia with erythropoietin. J Am Soc Nephrol 2 (1991) 927-936
31. Buckner F.S., Eschbach J.W., Haley N.R., Davidson R.C., and Adamson J.W. Hypertension following erythropoietin therapy in anemic hemodialysis patients. Am J Hypertens 3 (1990) 947-955
32. Song J.H., Park G.H., Lee S.Y., Lee S.W., Lee S.W., and Kim M.-J. Effect of sodium balance and the combination of ultrafiltration profile during sodium profiling hemodialysis on the maintenance of the quality of dialysis and sodium and fluid balances. J Am Soc Nephrol 16 (2005) 237-246
33. Song J.H., Lee S.W., Suh C.K., and Kim M.J. Time-averaged concentration of dialysate sodium relates with sodium load and interdialytic weight gain during sodium-profiling hemodialysis. Am J Kidney Dis 40 (2002) 291-301
34. Dolson G.M., Ellis K.J., Bernardo M.V., Prakash R., and Adrogue H.J. Acute decreases in serum potassium augment blood pressure. Am J Kidney Dis 26 (1995) 321-326
35. van Kuijk W.H., Mulder A.W., Peels C.H., Harff G.A., and Leunissen K.M. Influence of changes in ionized calcium on cardiovascular reactivity during hemodialysis. Clin Nephrol 47 (1997) 190-196
36. Henrich W.L., Hunt J.M., and Nixon J.V. Increased ionized calcium and left ventricular contractility during hemodialysis. N Engl J Med 310 (1984) 19-23
37. Sherman R.A., Bialy G.B., Gazinski B., Bernholc A.S., and Eisinger R.P. The effect of dialysate calcium levels on blood pressure during hemodialysis. Am J Kidney Dis 8 (1986) 244-247
38. Leunissen K.M., van den Berg B.W., and van Hooff J.P. Ionized calcium plays a pivotal role in controlling blood pressure during haemodialysis. Blood Purif 7 (1989) 233-239
39. Gabutti L., Bianchi G., Soldini D., Marone C., and Burnier M. Haemodynamic consequences of changing bicarbonate and calcium concentrations in haemodialysis fluids. Nephrol Dial Transplant 24 (2008) 973-981
40. Maynard J.C., Cruz C., Kleerekoper M., and Levin N.W. Blood pressure response to changes in serum ionized calcium during hemodialysis. Ann Intern Med 104 (1986) 358-361
41. van der Sande F.M., Cheriex E.C., van Kuijk W.H., and Leunissen K.M. Effect of dialysate calcium concentrations on intradialytic blood pressure course in cardiac-compromised patients. Am J Kidney Dis 32 (1998) 125-131
42. Kyriazis J., Katsipi I., Stylianou K., Jenakis N., Karida A., and Daphnis E. Arterial stiffness alterations during hemodialysis: the role of dialysate calcium. Nephron Clin Pract 106 (2007) c34-c42
43. Kyriazis J., Stamatiadis D., and Mamouna A. Intradialytic and interdialytic effects of treatment with 1.25 and 1.75 mmol/L of calcium dialysate on arterial compliance in patients on hemodialysis. Am J Kidney Dis 35 (2000) 1096-1103
44. Blacher J., Demuth K., Guerin A.P., Safar M.E., Moatti N., and London G.M. Influence of biochemical alterations on arterial stiffness in patients with end-stage renal disease. Arterioscler Thromb Vasc Biol 18 (1998) 535-541
45. Blacher J., Guerin A.P., Pannier B., Marchais S.J., Safar M.E., and London G.M. Impact of aortic stiffness on survival in end-stage renal disease. Circulation 99 (1999) 2434-2439
46. Mourad A., Khoshdel A., Carney S., et al. Haemodialysis-unresponsive blood pressure: cardiovascular mortality predictor?. Nephrology (Carlton) 10 (2005) 438-441
47. Doumas M.N., Douma S.N., Petidis K.M., Vogiatzis K.V., Bassagiannis I.C., and Zamboulis C.X. Different effects of losartan and moxonidine on endothelial function during sympathetic activation in essential hypertension. J Clin Hypertens 6 (2004) 682-689
48. Saijonmaa O., Metsarinne K., and Fyhrquist F. Carvedilol and its metabolites suppress endothelin-1 production in human endothelial cell culture. Blood Press 6 (1997) 24-28
49. Prasad V.S., Palaniswamy C., and Frishman W.H. Endothelin as a clinical target in the treatment of systemic hypertension. Cardiol Rev 17 (2009) 181-191
50. Flanigan M.J., Khairullah Q.T., and Lim V.S. Dialysate sodium delivery can alter chronic blood pressure management. Am J Kidney Dis 29 (1997) 383-391
51. Suri R.S., Nesrallah G.E., Mainra R., et al. Daily hemodialysis: a systematic review. Clin J Am Soc Nephrol 1 (2006) 33-42
52. Walsh M., Culleton B., Tonelli M., and Manns B. A systematic review of the effect of nocturnal hemodialysis on blood pressure, left ventricular hypertrophy, anemia, mineral metabolism, and health-related quality of life. Kidney Int 67 (2005) 1500-1508
53. Chan C.T., Li S.H., and Verma S. Nocturnal hemodialysis is associated with restoration of impaired endothelial progenitor cell biology in end-stage renal disease. Am J Physiol Renal Physiol 289 (2005) F679-F684